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SYSTEMATIC REVIEW Open Access
Effect of hospital volume on outcomes of
total hip arthroplasty: a systematic review
and meta-analysis
Syed Hamza Mufarrih1* , Muhammad Owais Abdul Ghani2, Russell Seth Martins3, Nada Qaisar Qureshi4,
Sayyeda Aleena Mufarrih5, Azeem Tariq Malik6 and Shahryar Noordin7
Abstract
Background: A shift in the healthcare system towards the centralization of common yet costly surgeries, such as
total hip arthroplasty (THA), to high-volume centers of excellence, is an attempt to control the economic burden
while simultaneously enhancing patient outcomes. The “volume-outcome” relationship suggests that hospitals
performing more treatment of a given type exhibit better outcomes than hospitals performing fewer. This theory
has surfaced as an important factor in determining patient outcomes following THA. We performed a systematic
review with meta-analyses to review the available evidence on the impact of hospital volume on outcomes of THA.
Materials and methods: We conducted a review of PubMed (MEDLINE), OVID MEDLINE, Google Scholar, and
Cochrane library of studies reporting the impact of hospital volume on THA. The studies were evaluated as per the
inclusion and exclusion criteria. A total of 44 studies were included in the review. We accessed pooled data using
random-effect meta-analysis.
Results: Results of the meta-analyses show that low-volume hospitals were associated with a higher rate of surgical
site infections (1.25 [1.01, 1.55]), longer length of stay (RR, 0.83[0.48–1.18]), increased cost of surgery (3.44, [2.57,
4.30]), 90-day complications (RR, 1.80[1.50–2.17]) and 30-day (RR, 2.33[1.27–4.28]), 90-day (RR, 1.26[1.05–1.51]), and 1-
year mortality rates (RR, 2.26[1.32–3.88]) when compared to high-volume hospitals following THA. Except for two
prospective studies, all were retrospective observational studies.
Conclusions: These findings demonstrate superior outcomes following THA in high-volume hospitals. Together
with the reduced cost of the surgical procedure, fewer complications may contribute to saving considerable
opportunity costs annually. However, a need to define objective volume-thresholds with stronger evidence would
be required.
Trial registration: PROSPERO CRD42019123776.
Keywords: Total hip arthroplasty, Hospital volume, THA, Low-volume hospitals vs. high-volume hospitals, THA
outcomes, Total hip replacement
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Background
Total hip arthroplasty (THA), a remarkably successful, safe,
and cost-effective treatment for pain and joint dysfunction
resulting from end-stage arthritis [1–4], is performed annu-
ally for approximately one million patients worldwide, with
over 300,000 patients in the USA [5]. These numbers are
expected to rise 174% by 2030, primarily driven by aging
populations and an increase in life expectancy [5]. Although
arthroplasty has shown promising results in reducing pain
severity and improving the joint function of the patients,
there is still room for improvement in terms of shortening
length of hospital stay (LOS) and decreasing risk of postoper-
ative dislocation, peri-prosthetic fracture, and infection to
effectively lower the overall cost of hip arthroplasty and revi-
sion rates.
Since the inception of modern THA in 1960 [6], vari-
ous studies have identified several factors that may affect
the outcomes of the surgery. These include patient-re-
lated factors such as age [7, 8], gender [9, 10], elevated
body mass index [11], number of comorbid conditions
[12, 13], American Society of Anesthesiologist (ASA)
grade [14], neuropsychiatric disorders [15, 16], and tech-
nical-factors such as surgical complexity, implant type,
head size, and bearing surfaces [17–20].
Recently, the concept of hospital factors has surfaced. It
has been shown that hospitals performing more treatments
of a given type exhibit better outcomes than hospitals per-
forming fewer. This is called the “volume-outcome” relation-
ship and several studies have observed this effect in total hip
arthroplasty, where the outcomes of hip arthroplasty in hos-
pitals which perform a higher number of hip arthroplasty
procedures annually are better than hospitals which perform
a fewer number [21–23]. As the current healthcare system
endeavors to implement value, centralization of common yet
costly surgeries, such as THAs, to high-volume centers of ex-
cellence may be an effective way to control the economic
burden. While several studies have investigated the hospital
volume relationship, no systematic review or meta-analysis
has been conducted to pool the results. In our study, we
combine data from all published studies to study the differ-
ences in outcomes of hip arthroplasty in high-volume and
low-volume hospitals.
Methods
The review follows the PRISMA guidelines [24].
Search strategy
A review of PubMed (MEDLINE), OVID MEDLINE,
Google Scholar, and Cochrane library review was con-
ducted for studies reporting the effect of hospital volume
on outcomes of total hip arthroplasty (THA), since 1980
to March 2019. In order to yield maximum results, the
keywords used were (“hospital volume” OR (“hospital”
AND “volume”) AND (“total hip arthroplasty” OR
“THA” OR “total hip replacement” OR “hip replace-
ment”). Duplicates were removed and titles of all studies
were screened as per the eligibility criteria. Any ambigu-
ity was resolved through screening the abstract. The full
text of articles that met the inclusion criteria was
reviewed. The references of the selected studies were
screened for potentially relevant studies.
Selection criteria
Studies reporting the effect of hospital volume on total
hip arthroplasty, published in English, with available
full texts, were selected. The inclusion criteria and the
exclusion criteria have been summarized in Table 1.
Two authors (SHM and ATM) independently screened
all abstracts from the initial search to assess eligibility
for inclusion.
Data extraction
Data extraction was done by two authors (MAOG and
RSM) independently using Excel 2011 software. Data ex-
traction variables were pretested using five papers. The
extracted parameters included author name, study de-
sign, study duration, number of hips included, reported
outcomes, mean age of study population, adjustment for
covariates, and percentage of patients lost to follow-up.
In addition to this, the cut-off for categorizing hospital
volume as high or low, reported complications, the OR/
RR or HR values along with their confidence interval
and p value were also extracted.
The number of patients in low-volume hospital (LVH)
and high-volume hospital (HVH) groups and complica-
tions (e.g., mortality, surgical site infection) were ex-
tracted for the meta-analysis from each study. In case,
raw data in terms of crude numbers was not reported,
efforts were made to contact the author via email to re-
quest them to provide us with the data necessary for the
inclusion of their study in the pooled analysis.
Table 1 Eligibility Criteria for studies included in the review
Inclusion criteria Exclusion criteria
1) Studies that compared the outcomes of low-volume hospitals (LVH) and high-volume hospitals (HVH)
for hip arthroplasty.
2) Articles in which the study population was undergoing primary or revision THA.*
3) Reported outcomes included perioperative morbidity/complication, in-hospital mortality, postoperative
mortality within 1 year, readmission, length of stay (LOS), and cost of surgery.
1) Less than 25 cases
2) Greater than 10% patients lost to
follow-up
3) Measured outcomes not reporting
significance of results
4) Studies not available in English
*Studies reporting relationships between hospital volume and hip arthroplasty following trauma/malignancy were excluded.
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Synthesis of results
The meta-analysis was performed using RevMan Version
5.3 (The Cochrane Collaboration, Copenhagen, Denmark)
for calculating pooled summaries and generating forest
plots. Meta-analysis was only possible if the retrieval of
sufficient data from the study or through contact with the
author had been successful.
There was considerable heterogeneity among the stud-
ies in the cutoffs for categorizing hospital volume as low
or high. To account for this, and other variations includ-
ing the fact that studies were performed in different
regions of the world, with differences in age groups and
technical surgical protocols, we decided to use the
Mantel-Haenszel random-effect model to report the
risk-ratio and heterogeneity (I2) in our analysis.
The random effect model assumes that the effect size is
obtained from a population of effect sizes. Therefore, the
effect size is derived from the sampling of an effect size at
random, in addition to measurement error (the inverse
function of the sample size). Because the random-effects
model considers the two sources of error in effect size,
they are able to yield a larger error term and less statistical
power than fixed-effect models. However, one could bene-
fit from random effect models over fixed-effect models be-
cause of its ability to generalize the result to a broader
universe of studies. These models specifically account for
the heterogeneity of studies through a statistical parameter
representing the inter-study variation. For the parameters
recorded in our review, the random-effect model was pre-
ferred for the pooling of the data in the meta-analysis.
For pooling means, we used the standard mean differ-
ence (SMD) instead of mean difference, so that we could
standardize the results of all studies to a uniform scale.
This was necessary as the mean values varied widely
from region to region (For example, the mean length of
stay in studies from Japan ranged between 25–60 days
postoperatively while the mean length of stay in studies
in the USA ranged between 4–10 days).
Fig. 1 PRISMA flow diagram for study selection
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The use of standard mean difference expresses the size
of the intervention effect in each study relative to the
variability observed in the study, rather than comparing
it with other studies. Therefore, the net effect deter-
mined is the pooled summary of the standard mean dif-
ference among each individual study, rather than a
comparison with the means of other studies. This was
used to compare the difference in length of stay and
cost of surgery between HVH and LVH. The length of
stay was reported by many studies in different parts of
the world, and the protocols they use for their surgeries
vary vastly. Similarly, the cost of the surgeries was re-
ported using different currencies at different times.
Such a model is useful to pool studies with such vast
heterogeneity.
We decided to pool surgical site infections as per the
CDC definition of surgical site infection, 1999 [25].
Quality appraisal of studies
We used the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) system to evalu-
ate the quality of studies in our review [26].
Results
This work has been reported in accordance with the
PRISMA (Preferred Reporting Items for Systematic Re-
views and Meta-Analyses) [27] and AMSTAR (Assessing
the methodological quality of systematic reviews) Guide-
lines [28].
Study selection
A preliminary total of 1342 studies were identified from
Google Scholar, PubMed, and Cochrane library. The re-
moval of duplicates yielded 982 studies. Through screen-
ing of titles and abstracts, 93 studies which fulfilled the
inclusion criteria were extracted. Following full-length re-
views, 49 studies were excluded based on the exclusion
criteria. Forty-four studies were included in the qualitative
review, and only 31 were included in the meta-analysis.
The process of study selection has been summarized in
the PRISMA flow diagram (Fig. 1: PRISMA flow diagram
for study selection).
Study characteristics
A total of 44 studies were included in the review. Forty-
two studies were retrospective studies where longitu-
dinal data was collected over a certain period of time
from pre-existing databases, while 2 were prospective.
Six studies had included both primary THA and revision
THA [23, 29–33]. The remaining 38 studies were fo-
cused solely on primary THA. Data from revision sur-
geries is described in Additional file 4. Only data from
primary THA was used to pool results in our analyses.
Twenty-four of the 44 studies were conducted in the
USA while the remaining were contributed by 11 unique
countries (details in Additional file 1). The average age
of the patient population was 67.7 years (reported by 28
studies). Overall, 43.3% of the patients were male and
56.7% of the patients were female (reported by 34 stud-
ies). Details of the study characteristics are summarized
in Additional file 1. A total of 38 studies had adjusted
for covariates (details in Additional file 2). Patient co-
morbid conditions including diabetes mellitus, obesity,
dyslipidemia, chronic kidney disease, heart disease,
hypothyroidism, chronic obstructive pulmonary disease,
peripheral vessel disease, and depression were only re-
ported by 13 studies (details in Additional file 5).
Outcomes and findings
These studies include data from 1988 to 2011. Detailed
results of data extraction on reported outcomes are pre-
sented in Additional file 3.
Surgical-site infections
A total of 8 studies [31, 34–40] totaling 200,950 hip
arthroplasties were pooled to compare the rates of
Fig. 2 Comparison of surgical site infections (1-year post-operatively) between low-volume and high-volume hospitals
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surgical-site infections SSI 1-year postoperatively between
LVH and HVH. We observed that surgical site infections
were more frequently observed in LVH with a risk ratio
(RR) of 1.25 (CI [1.01, 1.55]; I2 = 59%, p value = 0.04) (Fig 2
comparison of surgical site infections (1-year postopera-
tively) between low-volume and high-volume hospitals).
Four studies, which could not be added to the pooled-
analysis, also compared postoperative incidence of SSIs.
Two of the studies (Kaneko, et al. [41] and Soohoo et al.
[42]) reported a significantly higher rate of SSIs follow-
ing THA at low-volume hospitals while two studies
(Huang et al. [43]. and Makela et al. [44]) reported no
significant difference between low-volume and high-
volume hospitals.
Cost of surgery
Six studies [34, 36, 43, 45–47] totaling 129,893 hip
arthroplasties were pooled to compare the cost of Pri-
mary THA in LVH vs. HVH. Based on the results of the
random meta-analysis model, we found that the cost of
surgery is significantly higher in LVH with SMD of 3.44
(CI [2.57, 4.30]; I2 = 100%, p value < 0.00001) (Fig. 3:
comparison of cost of surgery between low-volume and
high-volume hospitals).
Three studies reporting differences in the cost of sur-
gery could not be included in the meta-analysis.
Courtney et al. [48] reported that THA procedures per-
formed at HVH had significantly lower total mean
hospital-specific charges. Frisch et al. [49] and Lavernia
et al. [50] found no significant difference between mean
hospital charges for THA performed at LVH and HVH.
Length of postoperative hospital stay
A total of 9 studies [36, 37, 41, 43, 45, 46, 51–53] total-
ing 232,691 hip arthroplasties were pooled to compare
the length of postoperative stay in LVH vs. HVH. Based
on the results of the random meta-analyses model, we
found that postoperative stay was significantly longer in
LVH with a SMD of 0.83 (CI [0.48, 1.18] I2 = 100%, p
value = 0.00001) (Fig. 4: comparison of length of stay be-
tween low-volume and high-volume hospitals.).
Three studies reporting length of stay in low-volume
and high-volume hospitals could not be included in the
meta-analysis. Doro, et al. [23], Makela et al. [44], and
Judge et al. [54] reported increased LOS in LVH as com-
pared to VHVH.
Complications during index hospitalization
A total of 5 studies [36, 37, 40, 43, 55] totaling 36,159
hip arthroplasties were pooled to compare the complica-
tions during index hospitalization between LVH and
HVH. Based on the results of the random meta-analysis
Fig. 3 Comparison of cost of surgery between low-volume and high-volume hospitals
Fig. 4 Comparison of length of stay between low-volume and high-volume hospitals
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model, we found that there is no significant difference in
rates of index hospitalization complications between
LVH and HVH, with RR = 0.90 (CI [0.49, 1.64] I2 = 91%,
p value = 0.73) (Fig. 5: comparison of complications dur-
ing index hospitalization between low-volume and high-
volume hospitals.).
Complications within 90 days postoperatively
A total of 3 studies [42, 55, 56] totaling 74,409 hip arthro-
plasties were pooled to compare the rates of complications
90 days postoperatively in LVH with HVH. Based on the
results of the random meta-analyses model, we found that
there is a significantly higher chance of 90-day complica-
tions in LVH as compared to HVH (RR = 1.80 (CI [1.50,
2.17] I2 = 52%, p value < 0.00001) (Fig. 6: comparison of
complications 90 days postoperatively between low-
volume and high-volume hospitals).
Although not included in the meta-analysis, Solomon
et al. and Katz (2001) et al. also report a higher inci-
dence of postoperative complications in LVH compared
to HVH.
Revision hip arthroplasty at 1-year postoperative
A total of 5 studies [36, 37, 40, 42, 57] totaling 361,440 hip
arthroplasties were pooled to compare the rates of revi-
sion THA between LVH and HVH. Based on the pooled
analysis, no significant difference was observed between
rate of revisions for surgeries performed in LVH and
HVH 1 year postoperatively; RR = 1.27 (CI [0.98, 1.65] I2
= 73%, p value = 0.07) (Fig. 7: comparison of revision hip
arthroplasty 1 year postoperatively between low-volume
and high-volume hospitals).
Revision hip arthroplasty at 3 years postoperative
Five studies [22, 57–60] totaling 509,155 hip arthroplas-
ties were pooled. No significant difference was observed
between rate of revisions for surgeries performed in
LVH and HVH; RR = 1.18 (CI [0.86, 1.62] I2 = 97%, p
value = 0.31) (Fig. 8: comparison of revision hip arthro-
plasty 3 years postoperative between low-volume and
high-volume hospitals).In addition to this, Pamilo et al.
[51], Makela et al. [44], and Manley et al. [61] also re-
ported that there was no significant association between
revision rates and hospital volume. In contrast, Judge
et al. [54] reported a higher hazard ratio of revision
arthroplasty 5 years postoperatively for HVH vs. LVH.
30-day mortality
Three studies [21, 33, 62] totaling 140,656 hip arthro-
plasties were pooled to compare the mortality rates
within 30 days postoperatively between LVH and HVH.
Based on the results of the random meta-analysis model,
we found a significantly higher mortality rate in LVH,
RR = 2.33 (CI [1.27, 4.28] I2 = 93%, p value = 0.006)
(Fig. 9: comparison of 30-day mortality between low-
Fig. 5 Comparison of complications during index hospitalization between low-volume and high-volume hospitals
Fig. 6 Comparison of complications 90 days postoperatively between low-volume and high-volume hospitals
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volume and high-volume hospitals (study by Taylor
et al. reported findings from 1994 and 1995 separately).
90-day mortality
A total of 4 studies [35–37, 40] totaling 58,688 hip
arthroplasties were pooled to compare mortality rates
within 90 days postoperatively between LVH and HVH.
Based on the results of the random meta-analysis
model, we found a significantly higher mortality rate in
LVH, RR = 1.26 (CI [1.05, 1.51] I2 = 0%, p value = 0.01)
(Fig. 10: comparison of 90-day mortality between low-
volume and high-volume hospitals.).
1-year mortality
Four studies, [36, 37, 62, 63] totaling 13,203 hip arthro-
plasties were pooled to compare mortality rates within 1
year postoperatively between LVH and HVH. Based on
the results of the random meta-analysis model, we see that
there is a significantly higher mortality rate in LVH, RR =
2.26 (CI [1.32, 3.88] I2 =72%, p value = 0.003) (Fig. 11:
comparison of 1-year mortality between low-volume and
high-volume hospitals.).
A few studies reporting postoperative mortality as an
outcome could not be included in the meta-analysis.
Two studies (Lavernia et al. [50] and Laura et al. [55])
stated no statistically significant difference in mortality
rates between LVH and HVH. However 7 studies
(Hughes et al. [64], Solomon et al. [65], Sharkey et al.
[66], Riley et al. [67], Judge et al. [54], Chien et al. [68],
and Doro et al. [23]) reported a significant inverse rela-
tion between hospital volume and mortality rate.
Postoperative thromboembolic events
Five studies, [35–37, 42] totaling 130,572 hip arthroplas-
ties were pooled to compare the rates post-operative
deep venous thrombosis between LVH and HVH. Based
on the results of the random meta-analysis model, we
found that there was no significant difference in the risk
of thromboembolic events 90 days postop; (RR = 1.16,
(CI [0.78, 1.72] I2 = 78%, p value = 0.46) (Fig. 12: com-
parison of postoperative deep venous thrombosis be-
tween low-volume and high-volume hospitals.).
Quality appraisal
All the studies included in this review are observational
studies, with 42 retrospective and 2 prospective, which
are considered low-grade studies as per the GRADE sys-
tem guidelines.
Discussion
Few systematic reviews have been conducted in the
realm of orthopedic surgery to study the volume-
outcome relationship. While knee arthroplasty [69],
shoulder arthroplasty [70], spine surgery [71], and hip
fractures [72] have been extensively studied, evidence of
Fig. 7 Comparison of revision hip arthroplasty 1 year postoperatively between low-volume and high-volume hospitals
Fig. 8 Comparison of revision hip arthroplasty 3-year postoperative between low-volume and high-volume hospitals
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the effect of hospital volume on total hip arthroplasty
has not been reviewed systematically to our knowledge.
Our review was based on observational studies from
several countries around the world with a predominant
contribution from the USA. In our review, we found that
THAs performed at LVH have a significantly higher risk
of surgical site infections, cost of surgery, length of stay,
90-day complications, and mortality (30-days, 90 days,
and 1 year) (Table 2).
We found a significantly higher risk of postoperative
surgical site infections (SSIs) in LVH compared with
HVH. The finding of SSI risk being higher in LVH as
compared to HVH may be linked to other factors. Previ-
ous literature has reported the association of SSIs with a
longer length of hospital stay and has linked a longer
length of stay to low-volume hospitals [73, 74]. Another
risk factor associated with SSIs is longer operative dur-
ation which has also been observed in low-volume hos-
pitals in previous literature [31, 75, 76]. In addition,
previous literature suggests that high-volume hospitals
may enjoy superior infection prevention measures [77].
Our results, though specific to THA, are in agreement
with findings of prior research showing higher risks of
SSI in LVH [78, 79].
Our findings also show an inverse relationship be-
tween hospital volume and cost of surgery. This may be
attributed to greater negotiating power of high-volume
hospitals because of higher numbers, greater efficiency,
and accelerated care pathways allowing expedited dis-
charge processes and more prudent use of ancillary ser-
vices at HVH resulting in significant cost savings for the
healthcare system and the patient [80].
Length of stay may be a complex variable to dissect as
it is a combined reflection of pre-operative, intra-
operative, and postoperative care. Previous literature has
reported associations among operative time, postopera-
tive complications, and length of stay [81–83]. Though
we did not find a significant difference between the post-
operative complications in HVH and LVH during their
hospital stay in our study, the key factors underlying this
complex relationship are potentially related to the super-
ior healthcare provision capacity of HVH including
availability of special care facility, infrastructure, special-
ist medicine care, physiotherapy, pain control anesthesia
teams, and other resources during all stages of care and
health economy of the country the study was conducted
in [35, 84]. This enables the hospitals to be better
equipped to deal with problems before they escalate to
serious complications [85, 86]. Although several intra-
operative factors may also play a role in determining the
length of stay between HVH and LVH, this has not been
studied in detail.
Although our findings show no significant difference be-
tween complications during the hospital stay, complications
Fig. 9 Comparison of 30-day mortality between low-volume and high-volume hospitals (study by Taylor et al. reported findings from 1994 to
1995 separately)
Fig. 10 Comparison of 90-day mortality between low-volume and high-volume hospitals.
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at 90 days were reported to be significantly higher in LVH
when compared to HVH. Soohoo [42] studied this exten-
sively and concluded that patient and surgeon factors heav-
ily influenced the risk of developing complications. Patient
factors associated with higher 90-day complications
included male gender, higher Charlson comorbidity score,
comorbid conditions such as diabetes and rheumatoid arth-
ritis [42]. While these may not be under the control of the
hospital, a shorter learning curve [87] in the presence
of better resources [85, 86, 88] may allow an increase in
the capacity of HVH to be proactive in identifying and
resolving issues before they can adversely influence out-
comes. Although our results show a higher 90-day
complication rate with low-volume hospitals, there is
no significant difference in 1-year and 3-year revision
rates between LVH and HVH. This may be due to pos-
sible loss to follow-up, visit to high-volume hospitals
for revisions or mortality (as seen in our findings).
From a monetary perspective, not only are hip replace-
ment surgeries at HVH cost-effective, they also have a
greater value per dollar spent in the long run as they are
associated with lower rates of complications, especially
surgical site infections. SSIs result in significant losses
with up to three-fold cost increase after orthopedic sur-
geries [89]. This is particularly alarming as the rates of
surgical site infections in the USA are on the rise [5, 90–
92] and reimbursements are being reduced or denied
[93]. Lower rates of 90-day complications are not only
better outcomes, but also saves the costs of readmission.
Additionally, HVH may have room to negotiate costs
with suppliers due to their large volumes. This translates
into decreased costs which benefit the patients and the
healthcare system.
In contrast, longer length of stay associated with LVH
following THA procedures leads to a significant overall
increase in expenditure. In total, around 300,000 THA
procedures are carried out annually in the USA [94]. Up
to 35% (105,000) of these are carried out in LVH [35,
95]. Given that the cost of 1 day of in-patient stay at a
hospital in the USA is approximately $2500 [96], each
additional day of stay is an additional annual expend-
iture of $262,500,000. This is excluding additional costs
incurred due to the higher rates of SSI and other short-
term (90-day post-THA) complications associated with
having THA at LVH.
Although there is much debate on the influence of ex-
perience of the surgeon and outcomes [97, 98], lower
mortality rate at 30 days, 90 days, and 1-year postopera-
tively in HVHs following hip arthroplasty may be because
health care professionals including doctors and staff may
have more experience and skill at HVH, with highly
evolved and efficient processes of patient care (such as tai-
lored diagnostic and treatment algorithms or guidelines),
leading to better patient outcomes [99, 100]. In addition
to this, the larger workforce and more system-level re-
sources to use in patient care allow HVHs to tackle un-
anticipated complications at all stages of care [99].
The better outcomes observed in HVH may best be
explained by two popular hypotheses which contribute
to positive feedback. First, “practice makes perfect”
Fig. 11 Comparison of 1-year mortality between low-volume and high-volume hospitals
Fig. 12 Comparison of postoperative deep venous thrombosis between low-volume and high-volume hospitals
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which means hospitals develop more effective skills as
they treat more patients [100] and second “selective re-
ferral” where physicians and hospitals with better out-
comes receive more referrals subsequently acquiring
larger volumes [101].
Limitations
There are several caveats in our study. We were not able
to review the intra-operative factors and the functional
rehabilitation of patients for comparison between LVH
and HVHs. This was because no studies have compared
these variables among LVH and HVHs. Additionally, the
hospital volume cutoff is not uniform across studies.
Katz [35] used < 10 procedures per year as the cut-off,
while Laucis [102] set < 100 cases per year as LVH. This
could be due to the rising popularity of arthroplasty to
treat end-stage osteoarthritis where the number of THA
and TKA increased from 343,000 in 2000 to 851,000 in
2012 and is further on the rise. Hospitals now perform
this procedure more frequently, and understandably, the
cut-offs have been raised over time as observed in more
recent studies. Studies have been conducted in 12
unique countries and variatons in volume thresholds
may have been contributed by economical, logistic, and
disease burden differences. Lastly, our review is based on
observational studies. Conducting a randomized control
trial (RCT) may have ethical and logistical barriers. Even
after 30 years of the first study comparing the outcomes
of THA in LVH and HVH, no RCT has been reported.
There is a need for stronger evidence, including pro-
spective cohorts, to re-visit this important topic using
larger datasets to define objective volume-thresholds/
benchmarks.
Conclusion
Our analysis shows that total hip arthroplasties per-
formed at low-volume hospitals have significantly higher
surgical site infection rates, length of stay, cost of sur-
gery, 90-day complications, and mortality rates (30 days,
90 days, and 1 year) compared with high-volume hospi-
tals. Randomized controlled trials and prospective
studies should be conducted to assess differences in
functional outcomes and intra-operative factors between
low-volume and high-volume hospitals using standard-
ized cut-offs for low- and high-volume hospitals.
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0.04
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